Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancerHan Wu, Wei Wang|OncoTargets and Therapy|2016Cited by 37
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Feng Wang, Zhiquan Luo et al.|European Journal of Cancer|2024Cited by 18